Pharmacovigilance Outsourcing Market Detail Analysis focusing on Key Players like Cognizant, Covance, Ergomed, Genpact, IBM Corporation, ICON, iGATE Corporation, iMED Global Corporation, Infosys, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Ora

MarketStudyReport.com Adds New Pharmacovigilance Outsourcing Market 2018 – 2024 research report providing information and data By Service, By Service Providers, Industry Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast spreading across 230 Pages with table and figures in it.

Germany pharmacovigilance outsourcing market was valued at USD 185.4 million in 2017, as a result of the presence of well-established players providing pharmacovigilance activities to major pharmaceutical companies. Germany based BPOs are well-known for knowledge processing IT services and with enormous client-base these companies acquire majority of the market share. Aforementioned factor along with growing cases of ADRs will favor the industry growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1434127/

Availability of cost-effective pharmacovigilance outsourcing services provided by leading CROs and BPOs in emerging economies such as India will prove beneficial for the industry growth. CROs and BPOs have skilled and staff dedicated on providing pharmacovigilance outsourcing services at a lower cost. Multinational pharmaceutical companies as well as the start-up biotechnology companies prefer pre and post marketing pharmacovigilance services that are available at comparatively lower cost. Low cost of outsourcing services will ensure high demand thereby, propelling the industry growth. However, outsourcing the pharmacovigilance activities may involve risk as clients will have no control over quality of drug safety analysis and platforms being utilized for assessing the ARDs that will restrain industry growth to some extent.

Pharmacovigilance Outsourcing Market will exceed USD 7.5 billion by 2024; as per a new research report. Pharmacovigilance outsourcing industry is anticipated to have considerable growth during the forecast timeframe owing to increasing preference by pharmaceutical and biopharmaceutical companies for outsourcing drug safety activities. Pharmaceutical companies that don?t have expertise in drug safety activities rely on CROs and BPOs for pharmacovigilance. Outsourcing pharmacovigilance activities helps the pharmaceutical, biotechnology and biopharmaceutical companies to gain professional and accurate insights on ADRs for a particular drug before it is marketed. Also, many companies carry out post marketing surveillance for drugs from CROs such as IQVIA. Therefore, high demand for partial and bundled outsourcing activities by companies such as Astra Zeneca will favor the industry growth in foreseeable future.

Pre-marketing pharmacovigilance outsourcing services segment was valued at USD 713.1 million in 2017 and is expected to have considerable revenue size over the forthcoming years. Pre-marketing pharmacovigilance outsourcing services include reporting adverse events encountered during the clinical trials. Many pharmaceutical companies involved in drug manufacturing, outsource drug safety activities associated with clinical trials to avoid the delays in drug approval process that should augment the segmental growth in near future.

CROs segment will grow at 15.9% by 2024 and has numerous growth opportunities that will flourish the segment even in future. CROs are firms that typically have gained expertise in providing efficient and accurate pharmacovigilance outsourcing services that will increase the demand for drug safety outsourcing. Moreover, majority of the revenue generated by CROs is due to the customized pharmacovigilance outsourcing services utilizing technologically advanced platform for drugs developed will favor segmental growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1434127/


Some of the eminent industry players operating in pharmacovigilance outsourcing industry include Accenture, Bioclinica, Clintec, Cognizant, Covance, Ergomed, Genpact, IBM Corporation, ICON, iGATE Corporation, iMED Global Corporation, Infosys, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PRA Health Sciences, SIRO Clinpharm, Symogen, Syneos Health, Tata Consultancy Services (TCS) and Tech Mahindra. These key industry players implement strategic initiatives such as mergers and acquisitions, development of new services that help them in sustaining market competition. For instance, in February 2016, Cognizant Technology Solutions Corporation engaged into new digital healthcare development platform to expand its business services. The firm introduced Cognizant Health TranZform, a new healthcare platform developed by Orion Health for empowering operational efficiency and making sound decisions regarding cost and quality of patient?s care and thus driving customer engagement. This strategic initiative will boost Cognizant?s revenue.

Table of content:

Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Pharmacovigilance Outsourcing Industry Insights
Chapter 4. Pharmacovigilance Outsourcing Market, By Service
Chapter 5. Pharmacovigilance Outsourcing Market, By Service Provider
Chapter 6. Pharmacovigilance Outsourcing Market, By Region
Chapter 7. Company Profiles

More Details on this Report At: https://www.marketstudyreport.com/reports/pharmacovigilance-outsourcing-market

Related Report:

Global Pharmacovigilance (Pv) Software Industry Market Research Report

Based on the Pharmacovigilance (Pv) Software industrial chain, this report mainly elaborates the definition, types, applications and major players of Pharmacovigilance (Pv) Software market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Pharmacovigilance (Pv) Software market.

https://www.marketstudyreport.com/reports/global-pharmacovigilance-pv-software-industry-market-research-report?utm_source=RR-PSR

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.